Cargando…
Delivering gene therapy for mucopolysaccharide diseases
Mucopolysaccharide diseases are a group of paediatric inherited lysosomal storage diseases that are caused by enzyme deficiencies, leading to a build-up of glycosaminoglycans (GAGs) throughout the body. Patients have severely shortened lifespans with a wide range of symptoms including inflammation,...
Autores principales: | Wood, Shaun R., Bigger, Brian W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511407/ https://www.ncbi.nlm.nih.gov/pubmed/36172050 http://dx.doi.org/10.3389/fmolb.2022.965089 |
Ejemplares similares
-
The role of innate immunity in mucopolysaccharide diseases
por: Parker, Helen, et al.
Publicado: (2018) -
Innate Immunity in Mucopolysaccharide Diseases
por: Mandolfo, Oriana, et al.
Publicado: (2022) -
Clinical Trials for Gene Therapy in Lysosomal Diseases With CNS Involvement
por: Sevin, Caroline, et al.
Publicado: (2021) -
A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke
por: Eyford, Brett A., et al.
Publicado: (2021) -
Corrigendum: A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke
por: Eyford, Brett A., et al.
Publicado: (2021)